Live Breaking News & Updates on Lobe Sciences|Page 4

Stay updated with breaking news from Lobe sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia™ & Company

VANCOUVER, British Columbia (BUSINESS WIRE) Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical Company committed to discovering and developing patient-focused medicines for Orphan and Rare diseases announced that on August 30, 2023 it signed an amendment to. ....

United States , British Columbia , United Kingdom , Lobe Sciences , American Biopharmaceutical Company , Lobe Sciences Ltd , North American Biopharmaceutical Company , Sickle Cell Disease , Selling Members , Transfer Documentation , Selling Member , Globe Shares , Orphan Drug Act , C Reactive Protein , African American , Middle East , New Chemical Entities ,

Lobe Sciences provides further details regarding Altemia acquisition

Lobe Sciences provides further details regarding Altemia acquisition
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Philipj Young , British Columbia Securities Commission , Lobe Sciences Ltd , Altemia Company , Lobe Sciences , British Columbia Securities , Middle East , Orphan Drugs , Pediatric Priority Review Voucher ,